Page 379 - Programme book for The International Liver Congress 2015, EASL ILC 2015

THURSDAY, APRIL 23, 2015 07:00 – 08:00

Synageva Biopharma Corp. Strauss 3
Would you figure it out? Differential diagnosis beyond the usual

Chairs:
Bernard Paulweber, Austria
Vlad Ratziu, France

Introduction
Bernard Paulweber, Austria, Vlad Ratziu, France

Case presentation
Patrick McKiernan, The United Kingdom

Case presentation
Vlad Ratziu, France

Lysosomal acid lipase deficiency - Differential diagnosis vs. NASH or NAFLD
Ali Canbay, Germany

Silent fibrosis and cirrhosis
Mark Bechter, The United States

THURSDAY, APRIL 23, 2015 18:30 – 20:00

Bristol-Myers Squibb Hall D
The new landscape in the management of hepatitis C:
recent evidence to advance clinical practice

Chair: INDUSTRY INFORMATION
Heiner Wedemeyer, Germany

Welcome and Introduction
Heiner Wedemeyer, Germany

The new landscape of HCV treatment: is a sustained cure for all patients living
with HCV achievable?
Heiner Wedemeyer, Germany

Optimising management of challenging HCV patient cases: learnings from
clinical trials and practice
Kosh Agarwal, The United Kingdom, Rafael Esteban, Spain, Vincent Leroy, France,
Jürgen K. Rockstroh, Germany

Audience discussion

Closing Remarks
Heiner Wedemeyer, Germany

Vienna, Austria • April 22–26, 2015 379